The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomyAnna J. Black, Peter C. Black, Joshua Griffin et al.|Urologic Oncology Seminars and Original Investigations|2019Cited by 44
Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International ConsortiumMaria Carmen Mir, Peter C. Black, Michele Marchioni et al.|European Urology Focus|2020Cited by 34
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancerDavid D‘Andrea, Shahrokh F. Shariat, Peter C. Black et al.|Urologic Oncology Seminars and Original Investigations|2020Cited by 23
Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancerSarah Einerhand, Laura S. Mertens, Anna J. Black et al.|World Journal of Urology|2022Cited by 10
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancerDavid D‘Andrea, Shahrokh F. Shariat, Peter C. Black et al.|World Journal of Urology|2021Cited by 5